Fendiline-evoked [Ca2+]i rises and non-Ca2+-triggered cell death in human oral cancer cells

被引:19
作者
Huang, C. C. [2 ]
Huang, C. J. [3 ,4 ]
Cheng, J. S. [5 ]
Liu, S. I. [6 ]
Chen, I. S. [6 ]
Tsai, J. Y. [6 ]
Chou, C. T. [1 ]
Tseng, P. L. [7 ]
Jan, C. R. [1 ]
机构
[1] Kaohsiung Vet Gen Hosp, Dept Med Educ & Res, Kaohsiung 813, Taiwan
[2] Tzu Hui Inst Technol, Dept Nursery, Pingtung, Taiwan
[3] Kaohsiung Med Univ, Grad Inst Med, Coll Med, Kaohsiung, Taiwan
[4] Kaohsiung Med Univ Hosp, Dept Psychiat, Kaohsiung, Taiwan
[5] Yongkang Vet Hosp, Dept Med, Tainan, Taiwan
[6] Kaohsiung Vet Gen Hosp, Dept Surg, Kaohsiung 813, Taiwan
[7] Kaohsiung Vet Gen Hosp, Dept Pharm, Kaohsiung 813, Taiwan
关键词
Ca2+ fendiline; Fura-2; oral cancer cells; thapsigargin; GABA(B) RECEPTOR MODULATORS; CALMODULIN ANTAGONISM; ALLOSTERIC MODULATORS; VENTRICULAR MYOCYTES; INTRACELLULAR CA2+; ANTIANGINAL DRUG; CYTOSOLIC CA2+; APOPTOSIS; INHIBITION; CHANNELS;
D O I
10.1177/0960327108097436
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
The effect of fendiline on cytosolic free Ca2+ concentrations ([Ca2+](i)) and proliferation has not been explored in human oral cancer cells. This study examined whether fendiline altered Ca2+ levels and caused cell death in OC2 human oral cancer cells. [Ca2+](i) and cell viability were measured using the fluorescent dyes fura-2 and WST-1, respectively. Fendiline at concentrations above 10 mu M increased [Ca2+](i) in a concentration-dependent manner. The Ca2+ signal was reduced partly by removing extracellular Ca2+. The fendiline-induced Ca2+ influx was sensitive to blockade of L-type Ca2+ channel blockers. In Ca2+-free medium, after pretreatment with 50 mu M fendiline, 1 mu M thapsigargin (an endoplasmic reticulum Ca2+ pump inhibitor)-induced [Ca2+](i) rises were inhibited; and conversely, thapsigargin pretreatment nearly abolished fendiline-induced [Ca2+](i) rises. Inhibition of phospholipase C with 2 mu M U73122 did not change fendiline-induced [Ca2+](i) rises. At concentrations between 5 and 25 mu M, fendiline killed cells in a concentration-dependent manner. The cytotoxic effect of 15 mu M fendiline was not reversed by prechelating cytosolic Ca2+ with BAPTA/AM. Collectively, in OC2 cells, fendiline induced [Ca2+](i) rises by causing Ca2+ release from the endoplasmic reticulum and Ca2+ influx from L-type Ca2+ channels. Furthermore, fendiline-caused cytotoxicity was not via a preceding [Ca2+](i) rise.
引用
收藏
页码:41 / 48
页数:8
相关论文
共 34 条
[1]   Apoptosis induced in neuronal cells by oxidative stress: role played by caspases and intracellular calcium ions [J].
Annunziato, L ;
Amoroso, S ;
Pannaccione, A ;
Cataldi, M ;
Pignataro, G ;
D'Alessio, A ;
Sirabella, R ;
Secondo, A ;
Sibaud, L ;
Di Renzo, GF .
TOXICOLOGY LETTERS, 2003, 139 (2-3) :125-133
[2]  
BAYER R, 1987, PHARMATHERAPEUTICA, V5, P103
[3]   INOSITOL TRISPHOSPHATE AND CALCIUM SIGNALING [J].
BERRIDGE, MJ .
NATURE, 1993, 361 (6410) :315-325
[4]   Elementary and global aspects of calcium signalling [J].
Berridge, MJ .
JOURNAL OF PHYSIOLOGY-LONDON, 1997, 499 (02) :291-306
[5]   Calcium signalling: More messengers, more channels, more complexity [J].
Bootman, MD ;
Berridge, MJ ;
Roderick, HL .
CURRENT BIOLOGY, 2002, 12 (16) :R563-R565
[6]   GABAB receptor modulators potentiate baclofen-induced depression of dopamine neuron activity in the rat ventral tegmental area [J].
Chen, Y ;
Phillips, K ;
Minton, G ;
Sher, E .
BRITISH JOURNAL OF PHARMACOLOGY, 2005, 144 (07) :926-932
[7]   Fendiline mobilizes intracellular Ca2+ in Chang liver cells [J].
Cheng, JS ;
Chou, KJ ;
Wang, JL ;
Lee, KC ;
Tseng, LL ;
Tang, KY ;
Huang, JK ;
Chang, HT ;
Su, W ;
Law, YP ;
Jan, CR .
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2001, 28 (09) :729-733
[8]   TNF-α induced altered signaling mechanism in human neutrophil [J].
Das, S ;
Bhattacharyya, S ;
Ghosh, S ;
Majumdar, S .
MOLECULAR AND CELLULAR BIOCHEMISTRY, 1999, 197 (1-2) :97-108
[9]   Inhibition by fendiline of the transient outward current in rat ventricular cardiomyocytes [J].
Fassbender, V ;
Wegener, JW ;
Shainberg, A ;
Nawrath, H .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1999, 33 (06) :905-911
[10]  
Florenzano F, 2006, ADV EXP MED BIOL, V557, P77